Compliance & Validation — Not documented by Atlas
Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?
AI-powered commercial insights platform that scores and prioritizes HCP engagement for pharma field teams.
ODAIA, headquartered in Toronto, Canada, provides MAPTUAL, an AI platform that analyzes prescribing, claims, and engagement data to score healthcare professionals and prioritize field-team targeting in near real time. The company raised a Series B round and publicly names large pharma customers. Its focus is HCP-level commercial targeting rather than patient identification, and buyers should evaluate data coverage for their specific markets.
36% — Limited coverage. Coverage score — how completely Atlas documents ODAIA across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.
Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?
cloud
Ask the vendor: What is your pricing model, and what drives total cost of ownership?
Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?
Mid-Size Biotech, Large Pharma, Top 20 Pharma, Commercial
Commercialization
Series B
Not captured in Atlas data — confirm directly. Excluded from the score above.
Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?
Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?